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Abstract
Background: Following damage to the intestinal epithelium, restoration of epithelial barrier integrity is triggered by a
robust proliferative response. In other tissues, focal adhesion kinase (FAK) regulates many of the cellular processes that are
critical for epithelial homeostasis and restitution, including cell migration, proliferation and survival. However, few studies to
date have determined how FAK contributes to mucosal wound healing in vivo.
Methodology and Principal Findings: To examine the role of FAK in intestinal epithelial homeostasis and during injury, we
generated intestinal epithelium (IE)-specific conditional FAK knockout mice. Colitis was induced with dextran-sulfate-
sodium (DSS) and intestinal tissues were analyzed by immunohistochemistry and immunoblotting. While intestinal
development occurred normally in mice lacking FAK, FAK-deficient animals were profoundly susceptible to colitis. The loss
of epithelial FAK resulted in elevated p53 expression and an increased sensitivity to apoptosis, coincident with a failure to
upregulate epithelial cell proliferation. FAK has been reported to function as a mechanosensor, inducing cyclin D1
expression and promoting cell cycle progression under conditions in which tissue/matrix stiffness is increased. Collagen
deposition, a hallmark of inflammatory injury resulting in increased tissue rigidity, was observed in control and FAK
knockout mice during colitis. Despite this fibrotic response, the colonic epithelium in FAK-deficient mice exhibited
significantly reduced cyclin D1 expression, suggesting that proliferation is uncoupled from fibrosis in the absence of FAK. In
support of this hypothesis, proliferation of Caco-2 cells increased proportionally with matrix stiffness in vitro only under
conditions of normal FAK expression; FAK depleted cells exhibited reduced proliferation concomitant with attenuated cyclin
D1 expression.
Conclusions: In the colon, FAK functions as a regulator of epithelial cell survival and proliferation under conditions of
mucosal injury and a mechanosensor of tissue compliance, inducing repair-driven proliferation in the colonic epithelium
through upregulation of cyclin D1.
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Introduction
The intestinal epithelium serves as a selective permeability
barrier, separating the intestinal lumen and its contents from
underlying tissues [1]. Breach of this mucosal barrier puts the host
at risk for infection and inflammation, thus requiring a rapid and
efficient response to injury. The restoration of tissue integrity
involves the coordinated interaction of various cell types,
deposition of extracellular matrix (ECM), release of soluble growth
factors, and upregulation of epithelial cell proliferation [1], [2].
Adhesion-mediated signaling between cells and the ECM plays
a critical role in maintaining tissue homeostasis as well as in the
response to tissue damage [1]. Focal adhesion kinase (FAK) is a
non-receptor tyrosine kinase that is involved in adhesion signaling
in multiple cell types, including those of epithelial derivation.
Through its kinase activity, FAK provides robust, anti-apoptotic
signals involving the PI3K/Akt and MAPK pathways [3].
Expression of dominant-negative FAK mutants in intestinal
epithelial cell lines leads to increased apoptosis due to the loss of
adhesion-mediated survival signals [4], [5]. Conversely, FAK over-
expression has been shown to suppress apoptosis by activating the
nuclear factor kappa B (NF-kB) pathway [6]. FAK also promotes
cell survival by binding to, and inducing the degradation of, the
tumor suppressor protein p53. The induction of cellular stress
through DNA damage, hypoxia and/or onocogene activation
induces p53-mediated transcription of genes involved in cell death
and cell cycle arrest, while at the same time inhibiting the
transcription of cell survival genes [7], [8]. Under these conditions,
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causing the degradation of p53 [9].
In addition to its role mediating cell survival, FAK has also been
shown to regulate cellular proliferation. In one mechanism, FAK
autophosphorylation at tyrosine 397 creates a binding site for Src
family kinases, which in turn promotes Src-dependent tyrosine
phosphorylation of FAK at other sites [10]. The adaptor molecule
Grb2 binds to phosphorylated tyrosine 925, initiating the Ras/
MEK/ERK signaling cascade and activation of Ets-like transcrip-
tion factors that promote cyclin D1 expression and progression
through the cell cycle [10], [11]. Independent of ERK activation,
FAK regulates a second transcription factor, Krupple-like factor 8
(KLF8), which binds to and upregulates the cyclin D1 promoter
[12]. Finally, FAK can function as a mechanosensor of tissue
rigidity, promoting proliferation in response to decreased tissue
compliance via the upregulation of cyclin D1 [13].
In this study, we investigated the role of FAK in intestinal
development and colonic injury using an intestinal epithelial (IE)-
conditional FAK knockout mouse model in which FAK is deleted
from both the small and large intestine. Loss of FAK in these mice
had no significant effect on intestinal development or function
under homeostatic conditions. However, colonic epithelial repair
was significantly impaired in the absence of FAK following
inflammatory injury induced by acute dextran sulfate sodium
(DSS) treatment. Mice lacking FAK exhibited earlier onset and
increased severity of disease relative to control animals, charac-
terized by more extensive edema, ulceration and disruption of
crypt architecture. Upon removal of DSS, control mice exhibited
rapid epithelial restitution and a coincident increase in epithelial
cell proliferation. Conversely, DSS treatment resulted in the
accumulation of p53 in FAK-deficient epithelial cells and
increased evidence of apoptosis as measured by activation of
caspase-3. In addition, proliferation was significantly impaired in
the FAK-deficient mice and this correlated with a reduction in
cyclin D1 levels, coincident with a failure to repair the epithelium.
Collagen deposition is a hallmark of inflammatory injury, and
has been reported to induce tissue stiffening (fibrosis) in
inflammatory bowel disease [14], [15]. As discussed above, FAK
functions as a mechanosensor of matrix rigidity and has been
shown to promote cell proliferation in response to increased tissue
stiffness by inducing cyclin D1 expression [13]. While collagen
deposition was observed in the colon following DSS treatment in
both WT and FAK-deficient animals, epithelial cyclin D1
expression was elevated only in control mice. A similar loss of
sensitivity to matrix stiffness and reduced cyclin D1 levels were
observed in Caco-2 intestinal epithelial cells depleted of FAK by
RNA interference. These findings suggest that FAK functions
in vivo both as a regulator of adhesion-mediated survival and
Figure 1. Characterization of intestinal epithelial-specific conditional FAK knockout mice. (A) PCR of DNA isolated from homogenized
tissues obtained from WT and FAK
DIEC mice. The FAK
f allele is 1.6 kb, the recombined locus 327 bp. (B) Whole mount X-Gal staining of tissues
extracted from WT and FAK
DIEC mice. (C) Immunoblot analysis of whole organ homogenates isolated from WT and FAK
DIEC mice. The vertical line
indicates non-contiguous lanes generated from a single exposure. (D) Immunoblot analysis of FAK and Pyk2 expressed in primary colonic epithelial
cells. The vertical line indicates non-contiguous lanes generated from a single exposure. (E) Ileum and colon sections were immunostained for FAK.
Bars represent 50 mm.
doi:10.1371/journal.pone.0023123.g001
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required to drive cell cycle progression in response to inflamma-
tory injury.
Results
FAK is dispensable for normal intestinal development
Mice harboring loxP-targeted FAK alleles (FAK
f/f) [16] and a
LacZ
f-STOP-f reporter allele at the ROSA26 locus [17] were
crossed with mice expressing Cre recombinase under the control
of the intestinal epithelial-specific villin promoter [18] (Fig. S1) to
generate mice in which FAK is deleted from the entire intestinal
epithelium (designated FAK
DIEC). Deletion of the FAK
f allele in
the ileum, cecum, and colon of FAK
DIEC animals was confirmed
by PCR (Fig. 1A). The specificity of FAK deletion was examined
by ß-galactosidase staining originating from excision of the stop
codon in the ROSA26 LacZ locus (Fig. 1B). While the ileum and
colon of FAK
DIEC mice stained positively for ß-galactosidase, the
corresponding tissues from control (phenotypically wild type,
hereafter designated WT) mice were negative. ß-galactosidase
staining was negative in the kidneys and lungs of both genotypes.
Protein analysis from whole organ tissue homogenates showed
greatly reduced levels of FAK in the ileum, cecum, and colon of
FAK
DIEC mice compared to WT littermates (Fig. 1C). In contrast,
FAK expression was normal in the lungs of FAK
DIEC mice.
Primary colon epithelial cells isolated from FAK
DIEC mice
contained nearly undetectable levels of FAK, whereas the related
kinase Pyk2 was expressed equivalently in both WT and FAK
DIEC
cells (Fig. 1D). These data were corroborated by immunohisto-
chemistry (IHC); epithelial cells throughout the villi and crypts
(including the base) of WT ileums and colons expressed FAK at
steady state, while tissues derived from FAK
DIEC mice were
negative (Figs. 1E and S2). This is in contrast to a recent report by
Ashton et al. showing weak FAK expression under homeostatic
conditions in the murine small intestine [19]. Consistent with our
findings, however, these authors found that homeostasis in the
small intestine was largely unaffected by loss of FAK, with normal
villus architecture and normal numbers of both proliferating and
apoptotic cells [19].
Villin is first expressed in the hindgut mesoderm at day 9 of
development, and is upregulated at days 14–15 coincident with the
development of intestinal villi [18]. Thus, FAK excision in villin-
Cre mice is predicted to begin at embryonic day 9 and be
complete by birth, making this an excellent model with which to
study the role of FAK in intestinal development and homeostasis.
Moreover, because villin is expressed in both the small and large
intestinal epithelium, the villin-Cre model allows analysis of the
entire intestinal epithelium from the proximal duodenum to the
distal colon. FAK
DIEC mice were born in the expected Mendelian
ratios, developed normally, and maintained body weights (Fig.
S3A). Villus architecture was normal in all regions of the intestine
(Figs. 1E and S3B) and expression/localization of E-cadherin and
ß-catenin, major components of epithelial adherens junctions [20],
were unchanged in the absence of FAK (Figs. S3C and D).
FAK
DIEC mice are more susceptible to DSS-induced colitis
To determine if the loss of FAK affects epithelial wound repair
in the colon, we utilized an inflammatory injury model in which
colitis is induced using dextran sodium sulfate (DSS) [21], [22].
Animals were given 2.5% DSS in their drinking water for 5 days,
followed by a 3–14 day recovery period. As shown in Fig. 2A, WT
mice began to lose weight at day 6 with a peak at day 9 (,10% of
body weight), after which they began to recover. In contrast,
FAK
DIEC mice exhibited much more severe weight loss (25–30%),
resulting in the need for all animals to be sacrificed by day 8. Peak
levels of diarrhea and visible fecal blood were observed on day 7 in
both genotypes, however the symptoms of colitis (blood in stool,
loose stool consistency) were greatly aggravated in FAK
DIEC mice
and correlated with a 3.5-fold higher level of disease activity
compared to control animals (Fig. 2B).
Damage to the colonic epithelium induced by DSS treatment is
generally repaired during the recovery period [23]. At day 3 of
DSS treatment, minimal changes were observed in the epithelium
of both mouse genotypes (Fig. 3A, panels b, g). Tissues from WT
controls remained largely intact at day 5 (panels c and iii), with
patchy ulceration and edema appearing by day 8 (3 days after DSS
removal; panels d and iv). Despite evidence of damage, epithelial
regeneration adjacent to ulcerated areas was apparent in these
mice (Fig. 3B, panel a, arrow shows epithelial cells overlaying the
adjacent wound bed). By day 19, restoration of normal colonic
epithelial architecture was observed in WT mice coincident with
the re-emergence of crypt structures (Fig. 3A, panels e and v;
Fig. 3B, panel b, arrow shows a site of re-epithelialization). In
contrast to WT mice, significant tissue damage was evident in
FAK
DIEC mice by day 5, characterized by pronounced edema,
mucosal ulceration and loss of normal crypt structure (Fig. 3A,
panels h and viii). By day 8, profound changes in FAK
DIEC colons
were evident; the majority of the colonic epithelium was denuded
and there was little evidence of epithelial regeneration (panels i,
and high magnification panel ix). These more severe pathological
Figure 2. FAK
DIEC mice are more sensitive to DSS treatment. 8–
12 week-old mice were fed 2.5% DSS for 5 days and allowed to recover
for up to 14 days. The mean percent change in body weight (A) and
disease activity index (B) are shown for 16 WT and 14 FAK
DIEC mice (days
0–5), 9 WT and 11 FAK
DIEC mice (days 6–8), and 5 WT mice (days 9–19).
Asterisks indicate values that are significantly different from WT mice at
the same time point (P,0.05).
doi:10.1371/journal.pone.0023123.g002
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of significant intestinal inflammation (Fig. S4). As discussed above,
the FAK
DIEC mice did not survive past day 8 due to the severity of
clinical symptoms.
To determine whether the morphological changes observed in
response to DSS treatment coincided with increased FAK
expression and/or autophosphorylation, colon sections from
untreated and DSS-treated WT mice were immunostained for
FAK (Fig. 3C). FAK expression remained essentially unchanged
after 5 days of DSS treatment and on day 8 of the recovery period
(Fig. 3C). These results were corroborated (through day 5) by
immunoblotting for total FAK expression in primary colon
epithelial cells (Fig. 3D, middle panel). Interestingly, FAK activity
as measured by autophosphorylation at tyrosine 397 (FAKp
Y397),
was undetected in untreated animals, increased slightly by day 3
and achieved robust activation levels by day 5 of DSS treatment in
control animals (Fig. 3D, upper panel). These results differ from
previous studies in the small intestine, where radiation-induced
injury was reported to induce a dramatic upregulation of FAK
expression [19]. Here we find that, while the level of FAK protein
remained unchanged, its activity was enhanced in response to
mucosal injury in the colon.
FAK expression is required for enhanced proliferation
following intestinal injury
It has recently been reported that mucosal regeneration
following injury depends initially on contraction of the surface
epithelium around the wounded area, followed by increased
Figure 3. FAK
DIEC mice exhibit severe signs of epithelial erosion and edema in response to DSS treatment. (A) Representative H&E-
stained colon sections from untreated and DSS-treated mice sampled at the indicated time points. Low magnification images (46) are presented in
panels a–i. Bars represent 200 mm. Higher magnification (206) sections (white boxes) are depicted in panels i–ix. Bars represent 50 mm. (B) Regions
indicated by black boxes in panels iv and v were enlarged to show detail. Arrows indicate epithelial cells overlaying ulcerated tissues. Bar represents
50 mm. (C) Colon sections from untreated or DSS-treated WT mice were immunostained for FAK at the indicated time points. Bars represent 500 mm
in the low magnification (46; panels a–c.) and 100 mm in the higher magnification (206; panels i–iii) images. (D) Immunoblot analysis of the
designated proteins expressed in primary colon epithelial cells isolated from untreated (lanes 1 and 2) or DSS-treated (lanes 3–6) WT and FAK
DIEC
mice. Immunoblots are representative of 2 independent experiments containing pooled lysates from 3 animals per genotype and time point.
doi:10.1371/journal.pone.0023123.g003
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proliferation in numerous cell types [11], [24], we stained colon
sections from untreated and DSS-treated mice to visualize the
proliferation marker ki67. In untreated WT and FAK
DIEC mice,
ki67-positive cells were restricted to the lower half of each crypt,
comprising ,18–20% of total crypt epithelial cells (Fig. 4A, panels
a, i, f, and vi and Fig. 4B). A similar distribution of proliferating
cells was observed through day 3 of DSS treatment, prior to signs
of overt intestinal injury (panels b, ii, g, and vii). In WT animals
the percentage of proliferating cells per crypt increased to 32% at
day 5 and to nearly 70% at day 8 post-DSS (panels c, iii, d and iv),
coincident with the epithelial regeneration seen by histological
analysis (see Fig. 3A, panels d and iv). After two weeks of recovery,
the percentage of ki67-positive cells per crypt in WT animals
gradually decreased (Fig. 4B). In contrast, the proliferative
response to DSS-induced injury was markedly attenuated in
FAK
DIEC mice. The percentage of ki67-positive cells per crypt fell
to 10% in these mice after 5 days of DSS treatment, and the few
proliferating cells that were visible were confined to the lowest
portion of each remaining crypt, adjacent to the basement
membrane (Fig. 4A panels h and viii). By day 8, crypt structures
were largely absent in these mice (Fig. S5); however, in those rare
instances where crypts were discernable (Fig. 4A, panels i and ix),
the percentage of ki67-positive cells was significantly lower than
that observed in WT mice at the same time point (Fig. 4B).
FAK-deficient epithelial cells express reduced levels of
cyclin D1
Cyclin D1 is an important regulator of cyclin-dependent kinases
and its expression promotes progression through the cell cycle
[25], [26]. FAK has been shown to modulate cyclin D1 levels in
fibroblasts, vascular smooth muscle cells, and mammary epithelial
cells [11], [13]. Moreover, FAK has been shown to be required for
upregulation of cyclin D1 coincident with the increased cell
proliferation that occurs during injury-induced ECM remodeling
[13]. To determine whether the loss of epithelial FAK modulates
cyclin D1 levels, lysates isolated from colonocytes of untreated and
day 5 DSS-treated animals were analyzed by immunoblot. Cyclin
D1 expression was somewhat elevated in samples from untreated
FAK
DIEC mice compared to WT controls (Fig. 4C, lanes 1 and 2).
Following DSS treatment, cyclin D1 was seen to increase in WT
colonocytes, while it underwent a significant decrease in the
FAK
DIEC cells (lanes 3 and 4). This may account for the impaired
proliferation seen in FAK-deficient intestinal epithelial cells after 5
days of DSS treatment.
FAK protects intestinal epithelial cells from p53-mediated
apoptosis during colitis
In addition to its role in adhesion-mediated cell proliferation,
FAK also promotes cell survival by maintaining low levels of the
tumor suppressor p53. Stress signaling can activate and stabilize
p53, leading to transcription of cyclin dependent kinase inhibitors,
such as p21/cip1 and p27/kip1, and the induction of apoptosis
[27], [28]. FAK can counteract such signaling by translocating to
the cell nucleus, where it provides a scaffold that stabilizes
complexes between p53 and the E3 ubiquitin ligase Mdm2,
thereby causing p53 degradation [9]. Immunoblotting of epithelial
cell lysates revealed that under homeostatic conditions, p53 was
maintained at low levels in both WT and FAK-deficient mice
(Fig. 5A, upper panels, lanes 1, 2). During DSS-induced injury,
p53 levels increased 3.5-fold in colonocytes from WT animals and
more than 10-fold in cells isolated from FAK
DIEC mice (lanes 3
and 4). Together these findings indicate that maintenance of low-
level p53 expression at steady state does not require FAK, but that
FAK acts to restrain epithelial p53 expression under conditions of
inflammatory injury.
Since elevated p53 levels can also promote cell death, we
investigated changes in cleaved-caspase 3 expression. Caspase 3 is
an executioner caspase that, when cleaved and activated, can
regulate mitochondrial events in the apoptotic pathway [29].
Similar to p53 expression, cleaved-caspase 3 levels were low in
both WT and FAK
DIEC mice under steady-state conditions.
(Fig. 5A, middle panels, lanes 1, 2). However, in response to DSS
treatment, active caspase 3 levels increased 5.5-fold in FAK-
deficient animals compared to 1.8-fold in WT mice (lanes 3, 4).
Next, TUNEL-staining was performed to determine if the elevated
levels of apoptotic markers observed in FAK
DIEC animals
correlated with increased cell death (Fig. 5B). TUNEL-positive
cells were localized to sites of tissue damage and therefore were
highly prevalent in the colons of FAK-deficient mice, which
exhibited greater tissue destruction in response to DSS treatment
(Fig. 3A).
Finally, FAK can provide survival signals by activation of
downstream signaling molecules including the mitogen-activated
protein kinases (MAPK) extracellular signal-regulated kinase 1
(ERK1) and ERK2 [7]. Immunoblotting of cell lysates revealed
that, as expected, ERK1/2 phosphorylation was low under
homeostatic conditions, and was robustly activated after the
induction of colitis. (Fig. 5A, lower panels). However, no difference
in ERK1/2 phosphorylation was observed between WT and
FAK
DIEC mice (lanes 3, 4). Taken together, these results show that
the loss of FAK from intestinal epithelial cells results in increased
p53 expression and increased sensitivity to cell death in response to
DSS treatment. However, this process is uncoupled from pro-
survival and/or proliferation signals generated via the ERK1/2
signaling pathway.
Collagen deposition following mucosal injury is
associated with FAK-dependent cellular proliferation in
WT mice
Collagen deposition in the submucosa and mucosa is a hallmark
of inflammatory bowel diseases, where it contributes to fibrosis
[23], [30]. Increased ECM protein deposition and matrix
crosslinking result in greater tissue stiffness [30], [31]. Interesting-
ly, recent findings have suggested that tissue stiffness stimulates
proliferation in a variety of cell types through a FAK-cyclin D1
dependent pathway [13]. Based on these data, we hypothesized
that the differences in colon epithelial cell proliferation observed
between WT and FAK
DIEC mice after DSS treatment could either
be due to diminished collagen deposition in the absence of FAK
and/or a failure of FAK
2/2 epithelial cells to respond to
proliferative cues from the ECM.
Collagen deposition was found to be elevated in colonic tissues
from both WT and FAK
DIEC mice at days 5 and 8 following DSS
treatment (Fig. 6A, see blue staining), indicating that both
genotypes were capable of generating a fibrotic response to
DSS-mediated colonic injury. In fact, it appears that higher levels
of collagen may be deposited in FAK-deficient colons compared to
WT animals following DSS treatment and this may be a
consequence of the more extensive tissue damage evident in these
mice. Despite elevated collagen, FAK
DIEC mice exhibited a
significantly attenuated proliferative response to mucosal injury.
To investigate whether FAK directly regulates the proliferative
response of intestinal epithelial cells to tissue rigidity, Caco-2
intestinal epithelial cells were depleted of endogenous FAK by
siRNA, then plated for 2 days on collagen-coated polyacrylamide
substrates of rigidities ranging from 300 Pa (similar to the rigidity
FAK Regulates Mucosal Wound Repair In Vivo
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[31]. FAK expression in siRNA-treated cells was reduced by
approximately 60% while Pyk2 levels remained unaffected
(Fig. 6B). Plating efficiency and adhesion of cells to the different
substrates was identical between siControl and siFAK treated cells
(data not shown). After 48 hours, the number of control cells
present on the low rigidity substrate (300 Pa) increased slightly
from the initial plating density (,1.3 fold; Fig. 6C). Control cells
plated on the higher rigidity substrate (4800 Pa) showed a larger
net gain (2-fold), indicative of greater survival/proliferation rates
on the more rigid substrate. In contrast, FAK-depleted cells
showed no significant net increase during this 48-hour period on
either of the matrix rigidities tested. These data demonstrate that
FAK regulates the proliferative response to matrix rigidity in these
intestinal epithelial cells.
Since the loss of FAK from intestinal epithelial cells in vivo
resulted in less proliferation coincident with reduced cyclin D1
expression after DSS treatment (Fig. 4), we next tested whether
FAK depletion in Caco-2 cells affected cyclin D1 levels when
plated onto substrates of high and low rigidity. Cyclin D1 was not
detected in either siControl- or siFAK-treated cells plated on the
low rigidity substrate (Fig. 6D, middle panel, lanes 1, 2), further
supporting our findings that Caco-2 cells fail to proliferate on soft
matrix even in the presence of FAK. Cyclin D1 was present in
siControl-treated cells cultured on the higher rigidity substrate
(4800 Pa; lane 3); however, we were unable to detect an increase
in FAK autophosphorylation under these conditions (data not
shown). In comparison, cyclin D1 levels were significantly lower in
the siFAK-treated cells (lane 4 and Fig. 6E), consistent with a
failure of these cells to proliferate under these conditions. Finally,
Figure 4. FAK controls proliferation in response to DSS treatment. (A) Colon sections from untreated and DSS-treated WT and FAK
DIEC mice
were immunostained for ki67 at the indicated time points. Bars represent 200 mm in low magnification (46; panels a–i) and 50 mm in higher
magnification (206; panels i–ix) images. (B) Percent ki67 positive cells per colonic crypt in WT and FAK
DIEC mice. Data shown are the means from 2
mice for each genotype and 40 total crypts at day 0, and 3 mice of each genotype and approximately 35–60 crypts for all other time points. Asterisks
denote values that are significantly different from the mean for WT mice at day 0. ‘ indicates values that are significantly different from the mean for
FAK
DIEC mice at day 0. # indicates values that are significantly different from the mean for WT mice at each time point. P,0.05. (D) Immunoblot
analysis of the designated proteins expressed in primary colon epithelial cells isolated from untreated (lanes 1 and 2) or Day 5 DSS-treated (lanes 3
and 4) WT and FAK
DIEC mice. Total cyclin D1 levels were quantified by densitometry, normalized to the amount of tubulin present in each sample, and
expressed relative to the basal level in untreated WT mice (see numbers beneath the immunoblot). Immunoblots are representative of 2 independent
experiments containing pooled lysates from 3 animals per genotype and time point.
doi:10.1371/journal.pone.0023123.g004
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that ERK1/2 phosphorylation was lower in cells plated onto soft
matrix, and was robustly activated after plating onto the high
rigidity substrate (Fig. 6F). Similar to our in vivo findings after DSS
treatment (Fig. 5A), no difference in ERK1/2 phosphorylation
was observed between control-treated or FAK-depleted cells
(lanes 3, 4).
Discussion
FAK is not required for normal intestinal development
and homeostasis
FAK has an established role in many cellular processes involved
in intestinal homeostasis, including cell proliferation, survival, and
migration [32]. Despite these functions, our studies show that
deletion of FAK in the intestinal epithelial cell lineage early during
development has no significant consequence on the architecture of
the small or large intestine under homeostatic conditions. A similar
result was reported when FAK was acutely deleted from small
intestinal crypts in adult animals; epithelial cell proliferation,
migration, differentiation, and survival all appeared normal within
this tissue under homeostatic conditions [19]. FAK is thought to
regulate these diverse cellular functions largely through its role in
adhesion signaling downstream of integrins, including ß1, ß3 and
ß5 integrin receptors [33], [34], [35]. Thus it is interesting that
conditional loss of FAK does not phenocopy loss of ß1 integrin
expression in intestinal crypts [36]. Using the same villin-Cre
transgenic model as we employed here, intestinal crypts lacking ß1
integrin exhibited hyperplasia and underwent aberrant enterocyte
differentiation in the absence of any environmental insult [36],
resulting in postnatal death between days 7 and 14 due to
malnutrition. One possible explanation for these differences is
functional redundancy between FAK and its only other family
member Pyk2, which we found is also expressed in the intestinal
epithelium (Fig. 1D). Pyk2 has been shown to control p53 levels,
cell cycle progression, and proliferation in ovarian carcinoma cells
that express both FAK and Pyk2, and in FAK
2/2 mouse embryo
fibroblasts that undergo upregulation of Pyk2 due to loss of FAK
[37]. Members of the Src family of kinases (SFKs) also perform
multiple functions in the adhesion-mediated control of prolifera-
tion, adhesion, spreading and migration [3], [34], [38]. Indeed,
SFKs have been shown previously to suppress apoptotic signaling
in both human and rodent enterocyte cell lines [4], [39], [40],
[41]. Based on these data, we suggest that the absence of any clear
phenotype exhibited by the FAK
DIEC mice during development
and under homeostatic conditions may be due to proliferation and
survival signals emanating from Pyk2 and/or other transducers of
integrin signaling.
FAK promotes cell survival and regulates the proliferative
response to intestinal epithelial injury
While the loss of FAK had no apparent effect on small or large
intestinal architecture or function under homeostatic conditions, it
had a profound outcome on the response to epithelial injury.
Indeed, our data indicate that FAK serves an essential role in
colonic epithelial regeneration by contributing to epithelial cell
survival and proliferation under conditions of mucosal injury. In
response to cellular stress, accumulation of the tumor suppressor
protein p53 stimulates the transcription of a number genes
promoting growth arrest and/or cell death. We found that FAK
activity increased in the colonic epithelium of WT mice following
DSS treatment and, while p53 levels also rose, they did not do so
to the same extent as in FAK
DIEC mice. Similarly, while
colonocytes from WT animals exhibited a slight increase in
activated-caspase 3 during colitis, this level rose dramatically in
FAK-deficient mice and was coincident with increased numbers of
TUNEL-positive cells. These data suggest that canonical FAK
signal transduction pathways are activated following DSS-induced
damage, which then promote cell survival by preventing an
increase in expression of p53 and other pro-apoptotic molecules.
These results are consistent with findings by Lim et al. [9], which
show FAK facilitates cell survival through enhanced p53
degradation under conditions of cellular stress. However, our
observations differ somewhat from those reported by Ashton et al.,
who showed that FAK expression (but not activity) was elevated in
the small intestine in response to gamma irradiation [19]. These
authors also reported that p53 expression remained unchanged in
response to DNA damage in FAK-deficient enterocytes [19].
These differences may reflect distinctions between injury models
Figure 5. p53 accumulates in the colons of FAK-deficient mice
during colitis. (A) p53, cleaved-caspase 3 and ERK1/2 present in
primary colon epithelial cells isolated from untreated (lanes 1 and 2) or
Day 5 DSS-treated (lanes 3 and 4) WT and FAK
DIEC mice were detected
by immunoblot. Total p53, cleaved-caspase 3 and phospho-ERK1/2
levels were normalized to the amount of total tubulin (for p53 and
cleaved-caspase 3) or total ERK1/2 present in each sample and
expressed relative to the basal level in untreated WT mice (see
numbers under each immunoblot). Immunoblots are representative of
2 independent experiments containing pooled lysates from 3 animals
per genotype and time point. (B) Representative images of TUNEL-
stained colon tissues from WT and FAK
DIEC mice after Day 5 DSS
treatment.
doi:10.1371/journal.pone.0023123.g005
FAK Regulates Mucosal Wound Repair In Vivo
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signaling between the small intestine and the colon.
In addition to higher than normal levels of p53, the reduced
epithelial proliferation observed in FAK-deficient mice also
coincided with significantly diminished cyclin D1 expression
following inflammatory injury (Fig. 4). Several reports link FAK
expression to the induction of cyclin D1 in cultured cells [11], [12].
Indeed, FAK promotes cyclin D1 transcription by stimulating the
expression of two transcription factors, an Ets-like transcription
factor and Kruppel-like factor 8 [11], [12]. Conversely, cyclin D1
mRNA expression is suppressed by expression of either FAK
Y397F
or FAK-related non kinase (FRNK, the non-catalytic carboxy
terminal domain of FAK) [13]. Interestingly, we found that ERK
activation in response to DSS treatment was independent of FAK.
Figure 6. Increased tissue rigidity leads to FAK-dependent cell proliferation. (A) Colon sections from untreated and DSS-treated WT and
FAK
DIEC mice were stained with Masson’s trichrome stain. Collagen appears blue, muscle stains dark red, cytoplasm stains pink and nuclei appear dark
brown. Bars represent 50 mm. (B) Caco-2 cells transfected with siControl or siRNA targeting FAK (siFAK) were lysed 72 hours post-siRNA transfection
and immunoblotted for total FAK and Pyk2. (C) 24 hours post-transfection, cells were inoculated (6 wells per conditions) onto a soft-plate96,
incubated for 48 hours, and quantified using the CyQuant NF proliferation assay. Data are representative of 2 independent experiments. (D) Caco-2
cells were transfected with siControl or siFAK for 24 hours before plating onto polyacrylamide gels with rigidities of 150 Pa or 4800 Pa, and cultured
for a further 48 hours. Cells were then lysed and immunoblotted for FAK, cyclin D1 and tubulin. (E) Cyclin D1 levels were normalized to the amount of
total tubulin and expressed relative to the amount of cyclin D1 in siControl-treated cells Data are representative of 3 independent experiments.
Asterisks denote values that are significantly different from siControl-treated cells (P,0.05). (F) Caco-2 cells were transfected and plated as described
in part D. Cells were then lysed and immunoblotted for phopho- and total ERK1/2. Phospho-ERK1/2 levels were normalized to total ERK1/2 and
expressed relative to the amount of phospho-ERK1/2 in siControl-treated cells plated onto the 150 Pa substrate (see numbers under the
immunoblot).
doi:10.1371/journal.pone.0023123.g006
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2 cells plated onto higher rigidity substrate. It has been reported
previously that physical forces such as cyclic deformation induce
Caco-2 cell proliferation in a FAK-ERK dependent manner [42].
However, our observations are consistent with findings by Klein et
al. indicating that the regulation of mitogenesis and cyclin D1
expression by extracellular matrix stiffness requires FAK rather
than ERK1/2. These results highlight the complex nature of the
cellular response to colonic injury and the fact that the
requirement for FAK during this process appears to be both cell
type- and context-specific.
FAK functions as a mechanosensor to control intestinal
epithelial proliferation
A hallmark of inflammatory injury is the deposition of collagen
matrix within the inflamed tissue [15], [23], [30], [43], [44].
Elevated collagen expression in the mucosa and submucosa of
DSS-treated animals induces fibrotic thickening and contributes to
increased rigidity within colonic tissues [23]. We found that
collagen deposition following DSS treatment in WT animals
coincided temporally with a marked increase in colonic epithelial
cell proliferation and elevated FAK activity. In addition to
increased stiffening, it is also possible that FAK activation occurs
in direct response to elevated levels of collagen and other ECM
components, such as fibronectin. Arterial stiffening due to vascular
injury promotes a similar proliferative response to damage [13],
and greater collagen matrix density in the mammary epithelium
increases tissue rigidity and promotes cellular proliferation and
tumorigenesis in a FAK-dependent manner [45]. These data are
consistent with our findings, in that FAK
DIEC mice showed
decreased cyclin D1 expression and an attenuated proliferative
response to inflammatory injury despite robust collagen deposition
in the injured colon.
Findings by Klein et al. suggest that cells respond to increasing
extracellular stiffness by regulating the degree to which FAK stably
associates with activated integrins independent of its kinase activity
[13]. This is highlighted by the fact that cells expressing
constitutively active FAK are unable to progress through the cell
cycle on low stiffness matrices [13], and is supported by our data
showing that, in the absence of damage and subsequent tissue
stiffening, FAK is not required to maintain homeostasis in the
colon (see model, Fig. 7A). During colitis, however, we hypothesize
that pathological changes in matrix elasticity within the colon
promote formation of FAK-integrin complexes, cyclin D1
upregulation and progression through the cell cycle (Fig. 7B).
Within this context, FAK also becomes activated and mediates cell
survival by maintaining low levels of pro-apoptotic molecules like
p53 and activated-caspase 3. In the absence of FAK, loss of
adhesion signaling leads to a reduction in cyclin D1 levels,
inhibited proliferation and an accumulation in p53 expression.
This is further supported by our in vitro data, which showed
impaired proliferation of FAK-depleted Caco-2 colonic epithelial
cells on more rigid substrates coincident with reduced levels of
cyclin D1.
The pressure to maintain the integrity of the epithelial barrier is
paramount to host survival. Re-epithelialization is therefore an
essential component of the healing process following gastrointes-
tinal damage associated with inflammatory bowel diseases. Under
conditions of stress, such as that induced by prolonged exposure to
inflammatory mediators, we suggest that FAK tips the balance in
favor of cell survival while coordinately promoting an appropriate
proliferative response required to regenerate damaged mucosal
surfaces. The current study also supports a potential mechanism
implicating FAK as a regulator of intestinal epithelial cell
proliferation through the mechanotransduction of signals emanat-
ing from the tissue matrix. By establishing the mechanisms
through which epithelial repair is regulated, it may be possible to
develop better treatment options for inflammatory bowel diseases.
Materials and Methods
Ethics statement
The animal studies were carried out in strict accordance with
the recommendations in the Guide for the Care and Use of
Laboratory Animals of the National Institutes of Health. The
protocol was approved by the University of Virginia Animals Care
and Use Committee (Protocol Number 3158). All efforts were
made to keep pain and suffering to a minimum.
Intestinal-specific conditional FAK knockout mice
Mice were generated as described in supplemental materials to
produce Villin
wt/CreFAK
f/fROSA26LacZ
f-STOP-f/f-STOP-f (designat-
ed FAK
DIEC) and Villin
wt/wtFAK
f/fROSA26LacZ
f-STOP-f/f-STOP-f
(designated WT) littermate controls. All mice are in a pure C57BL/
6 background. Animal experiments were approved by the
institutional animal care and use committee of UVA.
Genotyping of mice and analysis of Cre-mediated
recombination (see Methods S1)
Antibodies and reagents
Immunoblot and immunohistochemical analyses were per-
formed using the following antibodies: polyclonal phospho-
FAK
pY397 (BD Transduction Laboratories, San Jose, CA),
polyclonal anti-ERK1/2, polyclonal phospho-ERK1/2 and
monoclonal cleaved-cleaved caspase 3 were all from Cell Signaling
(Danvers, MA), polyclonal anti-FAK C-20, monoclonal anti-p53
and monoclonal anti-FAK A-17 were all from Santa Cruz
Biotechnology, Inc, (Santa Cruz, CA). Monoclonal anti-ki67 clone
TEC-3 (DakoCytomation, Denmark), monoclonal anti-E-cadherin
(BD Transduction Laboratories), monoclonal anti-ß-catenin
(Epitomics, Burlingame CA), monoclonal anti-Pyk2 (BD Trans-
duction Laboratories), polyclonal anti-cyclin D1 (Abcam, Cam-
bridge, MA) and monoclonal anti-gamma-tubulin (Sigma-Aldrich,
St. Louis, MO) were all purchased from the suppliers indicated.
siRNA transfection
20 mM siRNA oligonucleotides [46] targeting human FAK
(Dharmacon, Lafayette, CO) and non-targeting controls (siCon-
trol, Ambion, Austin, TX) were transfected using Lipofectamine
RNAi max (Invitrogen, Carlsbad, CA) according to manufactur-
er’s specifications.
ß-galactosidase staining
Organs were rinsed in cold phosphate-buffered saline (PBS),
fixed in 0.1 M sodium phosphate, 20 mM Tris pH 7.3, 5 mM
EGTA, 2 mM magnesium chloride, 0.25% glutaraldehyde, 1%
formaldehyde for 30 minutes, and stained overnight at 4uCi n
0.1 M sodium phosphate, 20 mM Tris pH 7.3, 2 mM magnesium
chloride, 5 mM potassium ferrocyanate, 5 mM potassium ferri-
cyanate, 0.1% deoxycholate, 0.2% NP40, 1 mg/mL 5-bromo-4-
chloro-3-indolyl-ß-D-galactopyranoside (X-Gal). Organs were
then washed in PBS, dehydrated in methanol, and placed in 2:1
benzylbenzoate:benzyl alcohol for 48 hours prior to visualization.
DSS treatment
8–12 week old mice were given 2.5% dextran sulfate sodium
(DSS; MP Biomedicals, LLC, Solon, OH) in their drinking water
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activity index (DAI) was calculated based on change in body
weight, presence of blood in the stool, and stool consistency, as
previously described [47]. The scores were determined as follows:
change in weight (0:,1%, 1: 1–5%, 2: 6–10%, 3: 11–15%, 4:
.15%), stool consistency (0: normal, 2: loose stools, 4: diarrhea),
and stool blood (0: negative, 2: positive, 4: gross bleeding). The
total score was then divided by 3. Following observation, colons
were excised, measured, and processed for analysis at the indicated
time points.
Immunostaining
Intestinal tissues were flushed with PBS and fixed overnight in
Bouin’s fixative (Ricca Chemical Company, Arlington, TX), 10%
formalin or snap-frozen in O.C.T. (Sakura Finetek U.S.A., Inc.,
Torrance, CA). Tissues were subsequently stained for H&E,
immunohistochemistry, or immunofluorescence (see Methods S2).
For the detection of apoptotic cells, TUNEL staining was
performed as per the manufacturer’s instructions (Roche,
Indianapolis, IN).
Protein isolation from intestinal epithelial cells
The ileum and colon were opened longitudinally, washed
extensively with Hank’s Buffered Salt Solution (HBSS), cut into 3–
5 mm pieces, and incubated on an orbital shaker in HBSS, 5%
FBS, 2 mM EDTA at 37uC for 20 minutes. The supernatants
were collected, filtered through a 100 mm filter, and spun at 4uC
for 10 minutes at 1800 rpm. Pellets were washed, lysed, and
analyzed by immunoblotting [48], [49]. For some experiments,
colon sections were flushed with ice-cold PBS containing protease
(1 mM PMSF, 0.15 U/ml aprotinin and 1 mg/ml each of
leupeptin, pepstatin and antipain) and phosphatase inhibitors
(1 mM EDTA, 1 mM NaF, 20 mM Na4P207 and 2 mM
Na3VO4). Colons were opened longitudinally and scraped to
isolate mucosal protein. Scrapped cells were placed in cold cell
extraction buffer (10 mM Tris, 100 mM NaCl, 1 mM EGTA, 1%
Triton X-100, 10% glycerol, 0.1% SDS, 0.5% deoxycholate
supplemented with protease and phosphatase inhibitors at the
concentrations listed above). Mucosal scrapings were briefly
homogenized with a Tissue Master 240 (Omni International,
Kennesaw, GA) on ice before centrifugation at 4uC for 10 minutes
at 13,000 rpm to remove cell membranes and debris. Lysates were
then analyzed by immunoblotting. To quantify changes in protein
expression levels densitometry was performed. Band intensities
were quantified using ImageJ (National Institutes of Health).
Soft-plate96 proliferation assays and polyacrylamide
substrates
Multiwell ‘‘soft-plates’’ were inoculated for cell growth assays on
substrates of increasing rigidity as described in Tilghman et al. [50]
(see Methods S3). Flexible polyacrylamide substrates were
generated on glass coverslips and adapted for cell culture using
Figure 7. Increased tissue rigidity drives cell cycle progression in a FAK-cyclin D1-dependent manner. (A) Under homeostatic or
physiological conditions, where tissue compliance is relatively high, FAK and integrin receptors are minimally associated and cyclin D1/proliferation
are kept to basal levels. p53 levels are also maintained at low levels. (B) Induction of colitis leads to the deposition of collagen and other ECM
components. The resultant increased tissue rigidity promotes FAK-integrin complexes, which in turn induces FAK phosphorylation and promotes cell
survival. FAK auto-phosphorylation can result in Akt activation and subsequent phosphorylation of Mdm2. FAK translocation to the nucleus also
allows FAK to function as a scaffold, stabilizing p53-Mdm2 complexes. Both of these FAK signaling pathways enhance cell survival by keeping p53
levels low. Finally, FAK contributes to the induction of cyclin D1 expression by upregulating transcription factors such as krupple-like factor 8 (KLF-8).
In the absence of FAK, the failure to increase cyclin D1 levels significantly attenuates proliferation and impairs the healing response.
doi:10.1371/journal.pone.0023123.g007
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al.
Statistical methods
A two-sample t-test, assuming unequal variance, was used to
determine statistical significance between conditions.
Supporting Information
Figure S1 Cre-mediated recombination in FAK
DIEC
mice. Schematic diagram of the FAK
f and ROSA26LacZ
f-STOP-f
loci following Villin-driven Cre-mediated recombination. The
second kinase domain exon of FAK (black box) is flanked by loxP
sites (black triangles). A stop codon on the ROSA26 locus is also
flanked by loxP sites (black triangles). Primers (short arrows) and
PCR products (thin lines) are shown for each allele.
(TIF)
Figure S2 Efficient FAK deletion occurs at the base of
intestinal crypts in FAK
DIEC mice. Ileum and colon sections
from WT and FAK
DIEC mice were immunostained for FAK.
Panels represent an enlarged region from crypts of ileum (a, b) and
colon (c, d). Images show positive FAK staining in the base of
crypts from WT animals that is absent in crypts from FAK
DIEC
animals. Bar represents 50 mm.
(TIF)
Figure S3 IEC-specific conditional FAK knockout mice
maintain normal weight patterns and gut architecture
compared to controls. (A) Average body weight in grams of 8–
10 week-old WT and FAK
DIEC mice. Data presented are the
average of 12 WT and 11 FAK
DIEC mice. (B) H&E stained ileum
and colon sections isolated from 8–10 week-old WT and FAK
DIEC
mice. (C) Immunoblot analysis of E-cadherin and ß-catenin
protein present in primary colonocytes isolated from WT and
FAK
DIEC mice. The vertical line separator is indicative of non-
contiguous lanes on the gel. However, immunoblots shown for
each antibody were generated from a single exposure. (D) Colon
sections from WT and FAK
DIEC mice were stained for E-cadherin
(green staining) and examined by immunofluorescence. Bars
represent 10 mm (panels a, b). Panels c and d represent enlarged
regions from panel a and b respectively. Arrows depict regions of
membrane-associated E-cadherin staining.
(TIF)
Figure S4 DSS-induced colonic shortening is aggravated
in FAK
DIEC mice. Colon length measured in centimeters from
untreated and DSS-treated WT and FAK
DIEC mice. Asterisks
indicate values that are significantly different from untreated WT
mice (Day 0). ‘ indicate values that are significantly different from
WT mice at the same time point. In both cases, p,0.05.
(TIF)
Figure S5 Colons of FAK
DIEC mice generally lack crypt
structure at day 8 post-DSS treatment. Low magnification
images of ki67-stained DSS-treated colon sections from WT (panel
a) and FAK
DIEC (panel b) animals (day 8). Bars represents 200 mm.
Panels c and d show high magnification images of panels a and b,
respectively. Bars represents 50 mm.
(TIF)
Methods S1 Genotyping of mice and analysis of Cre-
mediated recombination. Animals were genotyped using tail
DNA and subjected to PCR analysis. The following primers were
used for PCR of the FAK locus: P1 (59-GAGAATC-
CAGCTTTGGCTGTTG-39) and GenoRV (59-GAATGCTA-
CAGGAACCAAATAAC-39). This primer set generates 290-bp
(WT) and 400-bp (FAK
f) products. To determine the status of the
villin locus, the following primers were used: MR1878 (59-
GTGTGGGACAGAGAACAAACC-39) and MR1879 (59-
ACATCTTCAGGTTCTGCGGG-39). These primers generate
an 1100-bp (Villin-Cre) product. For PCR of the ROSA26 allele,
the following primers were used: ROSA1 (59- AAAGTCGCTCT-
GAGTTGTTAT-39), ROSA2: (59-GCGAAGAGTTTGTCCT-
CAACC-39) and ROSA3: (59- GGAGCGGGAGAAATGGA-
TATG-39). ROSA1 and ROSA3 primer sets generate a 600-bp
product containing the WT allele, while ROSA1 and ROSA2
primer sets generate a 300-bp product containing the ROSA26-
LacZ
f-STOP-f allele. To check for Cre-mediated recombination in
intestinal tissues, DNA was isolated from homogenates of intestinal
tissues (ileum, cecum, colon) and subjected to PCR. The following
primers were used: LoxP (59GACCTTCAACTTCT-
CATTTCTCCC-39) and GenoRV (see above). These primers
amplified products consisting of a FAK
f/f (1.6 kb), and a Cre-
mediated recombined fragment (327 bp). PCR fragments were
separated on 1.5% agarose gels.
(DOCX)
Methods S2 Preparation of tissue sections and immu-
nohistochemical staining. Ileum and colon tissues were
flushed with PBS to remove fecal material. Tissues were then
fixed overnight in Bouin’s fixative (Ricca Chemical Company,
Arlington, TX), 10% formalin or snap-frozen in O.C.T. (optimal
cutting temperature, Sakura Finetek U.S.A., Inc., Torrance, CA).
Following fixation, tissues were washed in 70% ethanol. Segments
were then embedded in paraffin directly or cut and mounted in
agar-10% formalin prior to being embedded in paraffin. Five-
micron paraffin sections were cut and mounted onto slides. For
immunohistochemical (IHC) staining, slides were deparaffinized in
a series of xylene and ethanol baths. Slides were treated in 0.3%
hydrogen peroxide to block endogenous peroxidase activity.
Antigen retrieval was performed by microwaving slides for
20 minutes in 10 mM sodium citrate buffer (pH 6.0). IHC
staining was performed utilizing a biotin blocking kit and
Vectastain ELITE ABC kit as per manufacturer recommendations
(Vector Laboratories, Burlingame, CA). Slides were incubated
with primary antibodies in PBS containing Vector blocking agent.
Biotinylated secondary anti-rat, anti-rabbit, or anti-mouse anti-
bodies (Vector Labs) were added and incubated for 10 minutes at
room temperature. Sections were then incubated with Nova Red
or 3,3-Diaminobenzidine (DAB) substrate (Vector Labs) followed
by a hematoxylin counterstain. For analysis of tissue architecture,
hematoxylin and eosin (H & E) staining was performed. To
visualize connective tissue, Masson’s trichrome staining was
performed. For immunofluorescence, five-micron frozen sections
were cut and mounted onto slides. Sections were blocked and
stained in 10% goat serum at room temperature. Sections were
incubated with primary antibodies for 1 hour followed by a
30 minute incubation with anti-mouse fluorescein isothyocyanate
(FITC)-conjugated secondary antibodies (Jackson ImmunoRe-
search, West Grove, PA). Cells were imaged with a Nikon Eclipse
E800 microscope connected to a charged-coupled device (CCD)
camera. Imaging was performed using Openlab software (Perkin
Elmer, Waltham, MA, USA). IHC- and H & E-stained sections
were examined with an Olympus BX51 microscope and images
were acquired with an Olympus DP70 digital camera controlled
by Image Pro Plus
TM software (EPIX, Inc, Buffalo Grove, IL).
(DOCX)
Methods S3 Soft-plate96 proliferation assays. To assay
cell growth on substrates of increasing rigidity, we employed the
use of a multiwell ‘‘soft-plate’’ as described in Tilghman et al. [49].
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PLoS ONE | www.plosone.org 11 August 2011 | Volume 6 | Issue 8 | e23123Soft-plate96 assay plates were seeded with siControl or siFAK-
treated cells in sextuplet wells 24 hours post-siRNA transfection at
a density of 5000 cells per well, and the cells were allowed to
proliferate for a further 48 hours. Cell proliferation was measured
using the CyQuant NF cell proliferation assay kit (Invitrogen,
Carlsbad, CA). Standard curves were generated for each
experiment by performing serial dilutions of the cells in an empty
row of wells and allowing them to adhere for four to six hours
prior to quantification with CyQuant.
(DOCX)
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